Clinical Scientist Director, Early Oncology Development

Amgen SA; España; Híbrido; EUR 120.000 - 170.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Health and welfare plans

Stock-based long-term incentives

Remote and hybrid work arrangements

Descripción de la vacante

Amgen seeks a Clinical Sciences Director – Early Development in Oncology to translate scientific strategy into actionable execution across early-phase trials. You will lead protocol execution oversight, medical data review, and data quality to enable decision-ready results.

You will collaborate with cross-functional teams, contribute to study concept development, protocol governance, and regulatory alignment, with a focus on data integrity and high-quality trial deliverables.

Formación

• Doctorate or Master’s with life sciences/healthcare experience.
• Experience in early-phase oncology drug development.
• Strong communication and presentation skills for leadership committees.

Responsabilidades

• Serve as clinical and scientific SME for oncology with protocol execution focus.
• Monitor clinical trials for data quality, trends, and risks.
• Collaborate across cross-functional teams to develop study concepts and protocols.
• Support regulatory submissions and clinical regulatory responses.
• Draft submissions and contribute to scientific publications.
• Lead data readouts, data cleaning, and interpretation of results.

Conocimientos

Clinical trial experience

Oncology

Regulatory submissions

Data analysis tools

Educación

Doctorate degree

Master’s degree

Bachelor’s degree

Herramientas

Spotfire

Descripción del empleo

Amgen seeks a Clinical Sciences Director – Early Development in Oncology to translate scientific strategy into actionable execution across early-phase trials. You will lead protocol execution oversight, medical data review, and data quality to enable decision-ready results.

You will collaborate with cross-functional teams, contribute to study concept development, protocol governance, and regulatory alignment, with a focus on data integrity and high-quality trial deliverables.